{
    "Trade/Device Name(s)": [
        "NIOX VERO Airway Inflammation Monitor",
        "NIOX VERO"
    ],
    "Submitter Information": "Aerocrine AB",
    "510(k) Number": "K150233",
    "Predicate Device Reference 510(k) Number(s)": [
        "K133898"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MXA"
    ],
    "Summary Letter Date": "January 30, 2015",
    "Summary Letter Received Date": "February 2, 2015",
    "Submission Date": "February 24, 2015",
    "Regulation Number(s)": [
        "21 CFR 862.3080"
    ],
    "Regulation Name(s)": [
        "Breath nitric oxide test system"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "misc"
    ],
    "Analyte(s)": [
        "Nitric Oxide (NO)",
        "Fractional exhaled nitric oxide (FeNO)"
    ],
    "Specimen Type(s)": [
        "Expired human breath"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "NIOX VERO unit",
        "NIOX Panel (PC application)"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical sensor",
        "Wireless Bluetooth communication",
        "USB communication"
    ],
    "Methodologies": [
        "Non-invasive quantitative measurement"
    ],
    "Submission Type(s)": [
        "System",
        "Analyzer",
        "Accessory",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for Aerocrine AB NIOX VERO Airway Inflammation Monitor activating Bluetooth for non-invasive breath nitric oxide measurement",
    "Indications for Use Summary": "Quantitative, non-invasive measurement of fractional exhaled nitric oxide in breath to evaluate asthma patients' response to antiinflammatory therapy in children (~7\u201317 years) and adults (18+ years), not for infants or children under 7, or for use in critical/emergency/anesthesiology settings",
    "fda_folder": "Toxicology"
}